CD&R, McKesson agree $5.8bn buyout of Option Care HealthBy Martin Holloway06/10/2026 CD&R and McKesson agree an Option Care Health buyout at $32.05 a share, valuing the infusion provider at roughly $5.8bn enterprise value.
